Fig. 3From: Synergistic cerium oxide nanozymes: targeting DNA damage and alleviating tumor hypoxia for improved NSCLC radiotherapy efficiency(A) Immunofluorescence microscopy image of A549 cells stained by CD44. (B) Immunofluorescence images of cultured A549 cells after 4 h of C/Q@ZIF-8-HA treatment. (C) and (D) The biocompatibility of C/Q@ZIF-8-HA on A549 cells at different concentration (0, 12.5, 25, 50, 75 and 100 µg ml− 1) after incubation for 12 and 24 h. Scale bar: 20 μmBack to article page